we pave the way for biotechs

News

Eckert & Ziegler subscribes to capital increase at BEBIG

2016-04-25 / At today’s meeting, the Board of Directors of Eckert & Ziegler BEBIG s.a. in Belgium resolved to propose to the Annual General Meeting on June 9, 2016 a capital increase with the exclusion of subscription rights of minority shareholders. Eckert & Ziegler AG, which already owns just under 75% of the dividend-bearing shares, will be the subscriber. With this subscription, the company will increase its shareholding to around 80%.

The planned capital inflow of some EUR 5 million is intended to strengthen the equity base and will be used to repay debt.  More details on the capital increase are available in the press release published by Eckert & Ziegler BEBIG s.a. on its website: http://www.bebig.com/international/press/press-releases.html

 

With around 700 employees, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world’s largest providers of isotope technology components for radiation therapy and nuclear medicine.

For further information or questions, please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 30 941084-138, karolin.riehle@ezag.de

www.ezag.de 

Back to the list

MDC
FMP
Charite
Campus Berlin-Buch
Berlin Buch